Although the coexistence of hairy cell leukemia with sarcoidosis has been reported in a few cases in the literature, in our case the patient had been dia gnosed and followed about 10 years with sarcoidosis and massive splenomegaly. It has been demonstrated that T helper 1 cells exist in organs infl uenced by sarcoidosis. These cells produce IL-2 and IFN-γ and induce a nonspecifi c infl ammatory response and granuloma formation. Also these cytokines may play a role in the development of hairy cell leukemia.
Introduction
Sarcoidosis is a multisystem granulomatous disorder of unknown etiology that aff ects individuals worldwide and is characterized pathologically by the presence of noncaseating granulomas in involved organs. It typically aff ects young adults. It has been estimated that the lifetime risk of sarcoidosis in caucasian population is 0.85% [1] .
Hairy cell leukemia (HCL) is an uncommon chronic B cell lymphoproliferative disorder, representing about 2% of all leukemias, and the median age at onset is 52; there is a strong male predominance of about four to one [2] .
In the present case study, we report a 67-year-old female who had been dia gnosed earlier as having sarcoidosis and was treated with corticosteroid therapy during 10-12 years. Afterwards, she was confi rmed to have HCL. The dia gnosis of HCL was established based on a combination of morphologic and immunophenotypic fi ndings.
Case report
A 67-year-old female was referred to our hospital in 2008 with a previous dia gnosis of sarcoidosis and a history of long-term use of oral and parenteral corticosteroids for symp tomatic treatment. At the time of presentation, she complained of dyspnea, progressive weakness, fatigue, photosensitivity and sensation of dry mouth developing a week after an upper respiratory tract infection. Constitutional symp toms such as weight loss, fever or night sweats were not present.
She had telangiectasias on her face, and her conjunctivae were pale and slightly icteric. Abdominal examination revealed hepatomegaly of 2 cm below the right subcostal margin and massive enlargement of the spleen, extending to the pelvic brim. Other physical fi ndings, including respiratory, cardiovascular and digital rectal examinations were unremarkable and enlargement of lymph nodes was not noticed.
A complete blood count at admis sion revealed hemoglobin (Hb) level of 65 g/ L, hematocrit (Hct) of 0.193, white blood cell (WBC) count of 3.1 × 10 9 / L and platelet (Plt) count of 112 × 10 9 / L. The erythrocyte indices and diff erential leukocyte counts were normal. Routine bio chip blood urea nitrogen (9.51 mmol/ L, normal: 2.50-7.34), indirect hyperbilirubinemia (17.1 μmol/ L mg/ dL, normal: 3.42-13.68), increased serum transaminase concentrations (62 U/ L, normal: 0-35) and markedly elevated levels of lactate dehydrogenase (2,048 U/ L, normal: 220-450) were found. Results of both direct and indirect Coombs tests were positive. Routine urine examination revealed the presence of proteinuria. The other bio chemical results, including erythrocyte sedimentation rate, were all within normal limits and the stool guaiac test was negative. The serological tests for various infectious agents (HBsAg, anti-HCV, anti-HIV 1 + 2, Parvovirus B19 Ig G/ M antibody levels, TORCH titers) were found to be negative. Ig G, A, M levels were within normal limits. ANA, anti SS-A (anti-Ro) and anti SS-B (anti-La) antibodies were not detected. Serum protein electrophoresis was normal. Evaluation of the peripheral blood smear showed 36% neutrophils, 48% lymphocytes, 15% monocytes, and 1% metamyelocytes with anisocytosis, poikilocytosis, numerous pencil cells, a few fragmented red blood cells and spherocytes, and a normal distribution of platelets. Bone marrow aspiration revealed a slightly hypercellular marrow with megaloblastic changes in all lineages and a myeloid-erythroid ratio of 0.5.
High resolution computed chest tomography demonstrated bilateral micro and macro nodular infi ltrates with lower lobe predominance, fi ndings suggestive of sarcoidosis. Abdominal ultrasonography and contrast-enhanced abdominopelvic computed tomography displayed an enlarged liver and spleen (19 cm and 30 cm in maximum diameter, resp.) and increased echogenicity of the liver parenchyma (Grade 2-3). DEXA scan of the lumbar spine and right hip showed low bone mineral density with a total T score of -4.6 and 1.5, resp. Tc-99m MDP whole-body bone scintigraphy revealed increased activity at the 12 th thoracic vertebra, which was compatible with a fracture line.
During hospitalization, the patient was treated with supportive care with multiple blood transfusions, received Pneumococcal, Meningococcal, and Haemophilus influenzae type B vaccinations and underwent a splenectomy for massive splenomegaly and hypersplenism. She was also started on prednisolone at a dose of 48 mg/ day, calcium and vitamin D supplements and once-weekly bisphosphonate therapy to reduce the risk of bone loss and fractures. Over the next 18 months, the dose of prednisolone was slowly tapered to a maintenance dose.
In December 2009, she returned with generalized weakness, severe fatigue, night sweats and fever. The patient's blood cell count at her second admis sion showed the following values: Hb: 91 g/ L, Hct: 0.277, WBC: 60 × 10 9 / L, Plt: 128 × 10 9 / L. Erythrocyte indices (MCV, MCH, and MCHC) were within the normal ranges, and the diff erential leukocyte count consisted of 64.1% lymphocytes, 30.5% monocytes, 5.0% neutrophils and 0.4% basophils. The reticulocyte count was 5.2%. Her peripheral blood and bone marrow smear showed atypical lymphocytes displaying cytoplasmic projections which were positive for tartrate-resistant acid phosphatase (TRAP). Immunophenotypic analysis of peripheral blood revealed neoplastic lymphoid cells brightly positive for CD11c, CD20, CD22, CD23, CD79b (cytoplasm), HLA DR, and slightly positive for CD5, CD10, CD18, CD25, CD79a (surface) and CD103, which was consistent with HCL. The dia gnosis of HCL was further confirmed by immunohistochemical staining of bone marrow bio psy. Cytogenetic analysis revealed karyotype of 47, XX, +16 in 18% of metaphases.
When the dia gnosis of HCL was established, she received a single cycle of cladribine (0.1 mg/ kg per day by continuous infusion for seven days). In present day, our patient is in a good physical condition, and all laboratory fi ndings including blood count are completely normal.
Discussion
HCL is an uncommon malignancy, representing about 2% of all leukemias, with approximately 600 to 800 new cases dia gnosed each year in the United Sta-chemical staining of bone marrow biopsy. Whether it is only a co-incidence or there is a causal relationship between HCL and sarcoidosis, merits further investigation.
